We are live on
!
Find out more
FQ
First Quadrant Portfolio holdings
AUM
$18M
1-Year Est. Return
24.2%
This Fund
S&P 500
This Quarter
Est. Return
+4.86%
1 Year Est. Return
+24.2%
3 Year Est. Return
+90.61%
5 Year Est. Return
+144.35%
10 Year Est. Return
–
AUM
$4.49B
AUM Growth
+$87.2M
(+2%)
Cap. Flow
-$70.7M
Cap. Flow
% of AUM
-1.57%
Top 10 Holdings %
Top 10 Hldgs %
16.01%
Holding
859
New
109
Increased
142
Reduced
182
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$26.9M |
| 2 |
Elevance Health
ELV
|
+$26.5M |
| 3 |
Gilead Sciences
GILD
|
+$20M |
| 4 |
Zebra Technologies
ZBRA
|
+$18.8M |
| 5 |
Johnson & Johnson
JNJ
|
+$18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$27.8M |
| 2 |
Packaging Corp of America
PKG
|
+$25.4M |
| 3 |
Amgen
AMGN
|
+$21.4M |
| 4 |
Hershey
HSY
|
+$20.5M |
| 5 |
Edison International
EIX
|
+$19.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.33% |
| 2 | Technology | 14.8% |
| 3 | Healthcare | 13.84% |
| 4 | Industrials | 13.25% |
| 5 | Energy | 11.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
TripAdvisor
TRIP
$1.7B
| $18.1M | 0.4% |
167,000
| – | – |
|
77
Dillards
DDS
$9.2B
| $18M | 0.4% |
154,135
+91,400
| +146% | +$9.54M |
|
|
ESRX
78
DELISTED
Express Scripts Holding Company
ESRX
| $17.9M | 0.4% |
258,760
+147,400
| +132% | +$10.4M |
|
|
BCR
79
DELISTED
CR Bard Inc.
BCR
| $17.8M | 0.4% |
124,200
-23,500
| -16% | -$3.36M |
|
|
GAP
80
The Gap Inc
GAP
$7.3B
| $17.7M | 0.39% |
425,425
| – | – |
|
81
Harley-Davidson
HOG
$2.61B
| $17.6M | 0.39% |
+252,500
| New | +$17.8M |
|
82
RenaissanceRe
RNR
$13.8B
| $17.3M | 0.39% |
162,100
+19,500
| +14% | +$2M |
|
83
Walmart Inc
WMT
$909B
| $17.2M | 0.38% |
688,914
-46,200
| -6% | -$1.19M |
|
84
Public Service Enterprise Group
PEG
$38.7B
| $16.8M | 0.37% |
411,600
+600
| +0.1% | +$23.3K |
|
|
HES
85
DELISTED
Hess
HES
| $16.4M | 0.37% |
166,030
+61,275
| +58% | +$5.53M |
|
86
Skyworks Solutions
SWKS
$9.2B
| $16.2M | 0.36% |
345,500
-5,800
| -2% | -$244K |
|
87
Williams-Sonoma
WSM
$27.5B
| $16M | 0.36% |
+445,400
| New | +$14.6M |
|
|
CB
88
DELISTED
CHUBB CORPORATION
CB
| $15.9M | 0.35% |
172,887
| – | – |
|
89
Boeing
BA
$169B
| $15.7M | 0.35% |
123,300
-2,300
| -2% | -$300K |
|
|
SNI
90
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $15.6M | 0.35% |
191,900
| – | – |
|
91
Cigna
CI
$78.4B
| $15.4M | 0.34% |
167,839
+99,000
| +144% | +$8.49M |
|
92
American International
AIG
$42.5B
| $15.1M | 0.34% |
276,176
| – | – |
|
93
Hormel Foods
HRL
$14.2B
| $15.1M | 0.34% |
610,600
-10,200
| -2% | -$247K |
|
94
Amdocs
DOX
$6.03B
| $14.8M | 0.33% |
319,800
-131,100
| -29% | -$6.17M |
|
95
Goldman Sachs
GS
$289B
| $14.6M | 0.33% |
87,360
-2,300
| -3% | -$371K |
|
96
Kimberly-Clark
KMB
$37.6B
| $14.6M | 0.32% |
136,946
+6,049
| +5% | +$643K |
|
|
CFN
97
DELISTED
CAREFUSION CORPORATION
CFN
| $14.6M | 0.32% |
328,450
| – | – |
|
98
Thermo Fisher Scientific
TMO
$214B
| $14.5M | 0.32% |
122,712
-156,192
| -56% | -$18.4M |
|
99
Lowe's Companies
LOW
$121B
| $14.2M | 0.32% |
296,400
-160,000
| -35% | -$7.46M |
|
100
DuPont de Nemours
DD
$18.6B
| $14.2M | 0.32% |
108,987
+18,480
| +20% | +$2.35M |
|
Similar funds
BC
SCM
CFG
AG
YEPV
WIA
LSM
FFIM
First Quadrant's Q2 2014 Portfolio in Review
As of Q2 2014, First Quadrant held 859 positions worth $4.49B, up 2% from $4.41B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
First Quadrant's Q2 2014 filing shows 109 new, 142 increased, 182 reduced and 54 closed positions. Its largest new stake was Harley-Davidson: 252,500 shares worth $17.6M. The largest sale was Biogen, an estimated $27.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- First Quadrant's largest Q2 2014 buy was Harley-Davidson: 252,500 shares worth $17.6M.
- First Quadrant added most to Merck in Q2 2014, an estimated $26.9M increase.
- First Quadrant's biggest Q2 2014 reduction was Biogen, cutting an estimated $27.8M.
- First Quadrant fully exited BALLY TECHNOLOGIES, INC. in Q2 2014, selling an estimated $14.7M.
- First Quadrant's ten largest holdings make up 16% of its $4.49B portfolio in Q2 2014.
- First Quadrant opened 109 new positions and closed 54 in Q2 2014.
- First Quadrant's portfolio value rose 2% quarter-over-quarter to $4.49B.
Based on First Quadrant's 13F filing for Q2 2014, filed 31 Jul 2014.